Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000037 |
|---|---|
| Form Type | 4 |
| Filing Date | May 1, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
15,000
Total Value
$358,384.30
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | May 1, 2026 | Exercise/Conversion | 5,000 | $7.80 | $39,000.00 | 241,984 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 1, 2026 | Sale | 2,200 | $62.58 | $137,685.46 | 239,784 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 1, 2026 | Sale | 1,800 | $64.15 | $115,467.84 | 237,984 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 1, 2026 | Sale | 300 | $65.10 | $19,530.00 | 237,684 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 1, 2026 | Sale | 400 | $66.06 | $26,422.00 | 237,284 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 1, 2026 | Sale | 200 | $67.16 | $13,431.00 | 237,084 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 1, 2026 | Sale | 100 | $68.48 | $6,848.00 | 236,984 | Direct | โ | View Details | |
Chief Operating Officer | Employee Warrant (right to buy) | Derivative | May 1, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 84,996 | Direct | โ | View Details |